QTORIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Oct 2026)
What this means for you
This application is over — abandoned 19 Oct 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97567266
- Mark type
- Word mark
- Filed
- 26 Aug 2022
- Published for opposition
- 25 Jul 2023
- Abandoned
- 19 Oct 2026
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin and macrolides of similar chemical structure acting on mammalian targets of rapamycin, by enabling and facilitating the placement of agents that act on mammalians for the delivery of rapamycin and macrolides of similar chemical structure in and on the skin
- Class 039 — Transportation and storage services: Delivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application
Owner
- Palvella Therapeutics, Inc., Wayne, PA, US
- Palvella Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 19 Oct 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Oct 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2026 — SOU EXTENSION 5 GRANTED
- 06 Mar 2026 — SOU EXTENSION 5 FILED
- 16 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2025 — SOU EXTENSION 4 GRANTED
- 19 Sept 2025 — SOU EXTENSION 4 FILED
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Mar 2025 — SOU EXTENSION 3 GRANTED
- 17 Mar 2025 — SOU EXTENSION 3 FILED
- 17 Mar 2025 — SOU TEAS EXTENSION RECEIVED